May 7, 2024, 06:28
Elisa Agostinetto: The long and winding road to biomarkers for immunotherapy
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on LinkedIn:
“The long and winding road to biomarkers for immunotherapy. A comprehensive analysis led by Laurence Buisseret of samples from patients with TNBC treated with pembrolizumab highlights the huge heterogeneity among TNBCs.
Now out in ESMO Open.”
Source: Elisa Agostinetto/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 18:36
Nov 18, 2024, 18:32
Nov 18, 2024, 18:06
Nov 18, 2024, 18:00
Nov 18, 2024, 17:40
Nov 18, 2024, 17:34